Number and percentage of individuals taking cardiovascular drugs that might have an effect on the inflammatory response or have haemorheological relevance
| Drug | Women | Men | p Value* |
|---|---|---|---|
| *Paired t test. | |||
| ACE, angiotensin converting enzyme; HMG-CoA, hydroxymethyl glutaryl coenzyme A. | |||
| Aspirin | 7 (3.6%) | 19 (9.9%) | 0.023 |
| Nitrates | 0 (0%) | 1 (0.5%) | NS |
| Amiodarone | 0 (0%) | 1 (0.5%) | NS |
| α Blockers | 0 (0%) | 7 (3.6%) | 0.016 |
| β Blockers | 13 (6.8%) | 12 (6.3%) | NS |
| Calcium channel blockers | 7 (3.6%) | 15 (7.8%) | NS |
| ACE inhibitors | 8 (4.2%) | 13 (6.8%) | NS |
| Angiotensin II receptor blocker | 4 (2.1%) | 2 (1.0%) | NS |
| HMG-CoA reductase blockers | 9 (4.7%) | 5 (2.6%) | NS |
| Fibrates | 3 (1.6%) | 2 (1.0%) | NS |